CEBRANOPADOL
Cebranopadol is a nociceptin and opioid receptor agonist providing potent analgesia with reduced respiratory depression. Side effects include nausea, dizziness, and somnolence. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Cebranopadol is a first-in-class analgesic acting as a mixed nociceptin/orphanin FQ peptide receptor (NOP) agonist and -opioid receptor (MOR) agonist. It activates Gi/o proteincoupled pathways, inhibiting adenylate cyclase, reducing neuronal excitability, and suppressing pain transmission. The dual NOP/MOR mechanism enhances analgesia while reducing classic opioid side effects such as respiratory depression and high abuse liability.
Benefits and Advantages
Used in pain-modulation research, NOP-receptor pharmacology, neuropathic-pain modelling, opioid-receptor signalling studies, analgesic-pathway comparisons, and behavioural addiction research. Offers unique mechanistic value for next-generation analgesics.
Side Effects and Risks
Risks include dizziness, nausea, mild respiratory effects, CNS depression and potential dependence at high doses. Handle under CNS-active opioid-agonist precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C24H27FN2O |
|---|---|
| Molecular Weight | 378.5 g/mol |
| CAS Number | 863513-91-1 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | Cebranopadol; 863513-91-1; GRT6005; 863513-93-3; Cebranopadol ((1alpha,4alpha)stereoisomer) |
| IUPAC/Chemical Name | 6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine |
| InChl Key | CSMVOZKEWSOFER-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


